meta-edc 0.3.7__py3-none-any.whl → 0.3.50__py3-none-any.whl
Sign up to get free protection for your applications and to get access to all the features.
- meta_ae/action_items.py +2 -2
- meta_ae/migrations/0017_auto_20221130_2257.py +12 -7
- meta_ae/tests/holidays.csv +1 -1
- meta_analytics/README.rst +17 -0
- meta_analytics/dataframes/__init__.py +19 -0
- meta_analytics/dataframes/constants.py +33 -0
- meta_analytics/dataframes/enrolled/__init__.py +1 -0
- meta_analytics/dataframes/enrolled/get_glucose_df.py +122 -0
- meta_analytics/dataframes/get_eos_df.py +26 -0
- meta_analytics/dataframes/get_last_imp_visits_df.py +101 -0
- meta_analytics/dataframes/glucose_endpoints/__init__.py +2 -0
- meta_analytics/dataframes/glucose_endpoints/endpoint_by_date.py +183 -0
- meta_analytics/dataframes/glucose_endpoints/glucose_endpoints_by_date.py +531 -0
- meta_analytics/dataframes/screening/__init__.py +2 -0
- meta_analytics/dataframes/screening/get_glucose_tested_only_df.py +20 -0
- meta_analytics/dataframes/screening/get_screening_df.py +163 -0
- meta_analytics/dataframes/utils.py +65 -0
- meta_analytics/get_tables.py +81 -0
- meta_analytics/tables/__init__.py +2 -0
- meta_analytics/tables/eligible.py +106 -0
- meta_analytics/tables/enrolled/__init__.py +0 -0
- meta_analytics/tables/enrolled/glucose.py +28 -0
- meta_analytics/tables/has_dm.py +61 -0
- meta_analytics/tests/__init__.py +0 -0
- meta_analytics/tests/test_endpoints_by_date.py +94 -0
- meta_auth/auth_objects.py +32 -3
- meta_auth/auths.py +18 -3
- meta_consent/action_items.py +18 -1
- meta_consent/admin/__init__.py +1 -0
- meta_consent/admin/subject_consent_v1_ext_admin.py +45 -0
- meta_consent/baker_recipes.py +5 -4
- meta_consent/consents.py +21 -2
- meta_consent/constants.py +1 -0
- meta_consent/forms/__init__.py +1 -0
- meta_consent/forms/subject_consent_v1_ext_form.py +16 -0
- meta_consent/locale/lg/LC_MESSAGES/django.po +69 -0
- meta_consent/locale/sw/LC_MESSAGES/django.po +12 -12
- meta_consent/migrations/0025_alter_historicalsubjectconsent_first_name_and_more.py +151 -0
- meta_consent/migrations/0026_historicalsubjectconsentv1ext_subjectconsentv1ext.py +544 -0
- meta_consent/migrations/0027_auto_20250111_0344.py +30 -0
- meta_consent/models/__init__.py +1 -0
- meta_consent/models/signals.py +34 -13
- meta_consent/models/subject_consent_v1.py +1 -3
- meta_consent/models/subject_consent_v1_ext.py +29 -0
- meta_consent/tests/holidays.csv +1 -1
- meta_consent/tests/tests/test_form_validators.py +1 -1
- meta_dashboard/locale/lg/LC_MESSAGES/django.po +30 -0
- meta_dashboard/locale/sw/LC_MESSAGES/django.po +11 -2
- meta_dashboard/navbars.py +3 -1
- meta_dashboard/templates/meta_dashboard/bootstrap3/buttons/eligibility_button.html +1 -1
- meta_dashboard/templates/meta_dashboard/bootstrap3/buttons/screening_button.html +1 -1
- meta_dashboard/templates/meta_dashboard/bootstrap3/screening/listboard.html +4 -4
- meta_dashboard/templates/meta_dashboard/bootstrap3/subject/dashboard/sidebar.html +24 -0
- meta_dashboard/templates/meta_dashboard/bootstrap3/subject/dashboard.html +3 -0
- meta_dashboard/templates/meta_dashboard/bootstrap3/subject/listboard.html +1 -2
- meta_dashboard/templatetags/meta_dashboard_extras.py +1 -1
- meta_dashboard/tests/holidays.csv +1 -1
- meta_dashboard/tests/urls.py +0 -1
- meta_dashboard/view_utils/__init__.py +6 -0
- meta_dashboard/view_utils/subject_screening_button.py +2 -2
- meta_dashboard/views/subject/dashboard/dashboard_view.py +38 -0
- meta_edc/__init__.py +7 -0
- meta_edc/celery.py +4 -13
- meta_edc/celery_live.py +18 -0
- meta_edc/celery_uat.py +24 -0
- meta_edc/management/commands/update_forms_reference.py +6 -2
- meta_edc/migrations/__init__.py +0 -0
- meta_edc/navbars.py +2 -1
- meta_edc/settings/debug.py +17 -9
- meta_edc/settings/defaults.py +82 -60
- meta_edc/settings/live.py +1 -9
- meta_edc/settings/uat.py +1 -14
- meta_edc/templates/meta_edc/bootstrap3/home.html +13 -7
- meta_edc/tests/tests/test_endpoints.py +22 -19
- meta_edc/urls.py +5 -2
- meta_edc/wsgi.py +1 -1
- meta_edc/wsgi_live.py +1 -1
- meta_edc/wsgi_uat.py +1 -1
- meta_edc-0.3.50.dist-info/AUTHORS +0 -0
- meta_edc-0.3.50.dist-info/METADATA +766 -0
- {meta_edc-0.3.7.dist-info → meta_edc-0.3.50.dist-info}/RECORD +400 -157
- {meta_edc-0.3.7.dist-info → meta_edc-0.3.50.dist-info}/WHEEL +1 -1
- {meta_edc-0.3.7.dist-info → meta_edc-0.3.50.dist-info}/top_level.txt +1 -0
- meta_pharmacy/admin/__init__.py +2 -0
- meta_pharmacy/admin/rx_admin.py +75 -0
- meta_pharmacy/admin/substitutions_admin.py +67 -0
- meta_pharmacy/admin_site.py +9 -0
- meta_pharmacy/apps.py +5 -0
- meta_pharmacy/constants.py +10 -0
- meta_pharmacy/forms/__init__.py +2 -0
- meta_pharmacy/forms/rx_form.py +16 -0
- meta_pharmacy/forms/substitutions_form.py +54 -0
- meta_pharmacy/label_configs.py +30 -0
- meta_pharmacy/labels/__init__.py +5 -0
- meta_pharmacy/labels/draw_label_for_subject_with_barcode.py +62 -0
- meta_pharmacy/labels/draw_label_for_subject_with_code128.py +14 -0
- meta_pharmacy/labels/draw_label_with_test_data.py +26 -0
- meta_pharmacy/labels/label_data.py +14 -0
- meta_pharmacy/labels/print_sheets.py +97 -0
- meta_pharmacy/list_data.py +8 -0
- meta_pharmacy/management/__init__.py +0 -0
- meta_pharmacy/management/commands/__init__.py +0 -0
- meta_pharmacy/management/commands/update_initial_pharmacy_data.py +10 -0
- meta_pharmacy/migrations/0002_initial.py +695 -0
- meta_pharmacy/migrations/0003_auto_20240909_2335.py +64 -0
- meta_pharmacy/migrations/0004_alter_historicalsubstitutions_report_datetime_and_more.py +23 -0
- meta_pharmacy/migrations/0005_auto_20240911_0352.py +17 -0
- meta_pharmacy/migrations/0006_lotnumber_label.py +289 -0
- meta_pharmacy/migrations/0007_lotnumber_medication.py +24 -0
- meta_pharmacy/migrations/0008_remove_lotnumber_medication_and_more.py +390 -0
- meta_pharmacy/migrations/0009_remove_historicalrx_slug.py +17 -0
- meta_pharmacy/models/__init__.py +3 -0
- meta_pharmacy/models/label_data.py +38 -0
- meta_pharmacy/models/rx.py +18 -0
- meta_pharmacy/models/rx_label.py +39 -0
- meta_pharmacy/models/substitutions.py +88 -0
- meta_pharmacy/urls.py +8 -0
- meta_pharmacy/utils/__init__.py +1 -0
- meta_pharmacy/utils/update_initial_pharmacy_data.py +146 -0
- meta_prn/action_items.py +52 -2
- meta_prn/admin/__init__.py +3 -0
- meta_prn/admin/dm_referral_admin.py +49 -0
- meta_prn/admin/offschedule_dm_referral_admin.py +47 -0
- meta_prn/admin/onschedule_dm_referral_admin.py +39 -0
- meta_prn/admin/pregnancy_notification_admin.py +6 -2
- meta_prn/baker_recipes.py +8 -1
- meta_prn/choices.py +2 -1
- meta_prn/constants.py +4 -1
- meta_prn/forms/__init__.py +2 -0
- meta_prn/forms/dm_referral_form.py +40 -0
- meta_prn/forms/offschedule_dm_referral_form.py +35 -0
- meta_prn/forms/offschedule_form.py +6 -0
- meta_prn/migrations/0034_auto_20220630_1110.py +3 -3
- meta_prn/migrations/0035_auto_20220630_1140.py +59 -56
- meta_prn/migrations/0057_historicalonscheduledmreferral_and_more.py +1156 -0
- meta_prn/migrations/0058_dmreferral_referral_note_and_more.py +29 -0
- meta_prn/migrations/0059_alter_historicaloffstudymedication_reason_and_more.py +53 -0
- meta_prn/models/__init__.py +13 -2
- meta_prn/models/dm_referral.py +39 -0
- meta_prn/models/offschedule.py +15 -1
- meta_prn/models/onschedule.py +6 -0
- meta_prn/models/signals.py +41 -1
- meta_prn/tests/tests/test_dm_referral.py +203 -0
- meta_reports/__init__.py +1 -0
- meta_reports/admin/__init__.py +15 -0
- meta_reports/admin/dbviews/__init__.py +14 -0
- meta_reports/admin/dbviews/glucose_summary_admin.py +116 -0
- meta_reports/admin/dbviews/imp_substitutions_admin.py +101 -0
- meta_reports/admin/dbviews/missing_screening_ogtt_admin/__init__.py +2 -0
- meta_reports/admin/dbviews/missing_screening_ogtt_admin/note_model_admin.py +53 -0
- meta_reports/admin/dbviews/missing_screening_ogtt_admin/unmanaged_model_admin.py +84 -0
- meta_reports/admin/dbviews/on_study_missing_lab_values_admin/__init__.py +1 -0
- meta_reports/admin/dbviews/on_study_missing_lab_values_admin/unmanaged_model_admin.py +13 -0
- meta_reports/admin/dbviews/on_study_missing_values_admin/__init__.py +1 -0
- meta_reports/admin/dbviews/on_study_missing_values_admin/unmanaged_model_admin.py +13 -0
- meta_reports/admin/dbviews/patient_history_missing_baseline_cd4_admin.py +58 -0
- meta_reports/admin/dbviews/unattended_three_in_row2_admin.py +47 -0
- meta_reports/admin/dbviews/unattended_three_in_row_admin.py +35 -0
- meta_reports/admin/dbviews/unattended_two_in_row_admin.py +34 -0
- meta_reports/admin/endpoints_admin.py +14 -0
- meta_reports/admin/endpoints_all_admin.py +13 -0
- meta_reports/admin/last_imp_refill_admin.py +181 -0
- meta_reports/admin/list_filters.py +30 -0
- meta_reports/admin/modeladmin_mixins.py +112 -0
- meta_reports/admin_site.py +5 -0
- meta_reports/apps.py +1 -16
- meta_reports/forms/__init__.py +1 -0
- meta_reports/forms/missing_ogtt_note_form.py +33 -0
- meta_reports/management/__init__.py +0 -0
- meta_reports/management/commands/__init__.py +0 -0
- meta_reports/management/commands/generate_endpoints.py +13 -0
- meta_reports/migrations/0001_initial.py +87 -0
- meta_reports/migrations/0002_patienthistorymissingbaselinecd4_and_more.py +64 -0
- meta_reports/migrations/0003_auto_20240618_0505.py +12 -0
- meta_reports/migrations/0004_alter_patienthistorymissingbaselinecd4_table.py +17 -0
- meta_reports/migrations/0005_endpoints.py +47 -0
- meta_reports/migrations/0006_endpoints_baseline_datetime.py +18 -0
- meta_reports/migrations/0007_alter_endpoints_endpoint_label_and_more.py +43 -0
- meta_reports/migrations/0008_alter_endpoints_endpoint_label.py +18 -0
- meta_reports/migrations/0009_alter_endpoints_options.py +21 -0
- meta_reports/migrations/0010_alter_patienthistorymissingbaselinecd4_options_and_more.py +49 -0
- meta_reports/migrations/0011_auto_20240813_0156.py +54 -0
- meta_reports/migrations/0012_auto_20240813_1516.py +48 -0
- meta_reports/migrations/0013_auto_20240813_1516.py +48 -0
- meta_reports/migrations/0014_auto_20240813_1517.py +48 -0
- meta_reports/migrations/0015_alter_endpoints_site.py +22 -0
- meta_reports/migrations/0016_missingscreeningogtt.py +47 -0
- meta_reports/migrations/0017_auto_20240819_1711.py +166 -0
- meta_reports/migrations/0018_auto_20240819_1713.py +54 -0
- meta_reports/migrations/0019_auto_20240819_1721.py +54 -0
- meta_reports/migrations/0020_auto_20240819_1811.py +54 -0
- meta_reports/migrations/0021_auto_20240819_1817.py +54 -0
- meta_reports/migrations/0022_auto_20240819_1832.py +54 -0
- meta_reports/migrations/0023_endpoints_meta_report_subject_a56b22_idx.py +20 -0
- meta_reports/migrations/0024_glucosesummary.py +38 -0
- meta_reports/migrations/0025_auto_20240822_0115.py +87 -0
- meta_reports/migrations/0026_auto_20240822_0120.py +54 -0
- meta_reports/migrations/0027_auto_20240822_0140.py +54 -0
- meta_reports/migrations/0028_alter_glucosesummary_options.py +22 -0
- meta_reports/migrations/0029_auto_20240822_0149.py +54 -0
- meta_reports/migrations/0030_auto_20240822_1637.py +54 -0
- meta_reports/migrations/0031_endpointsproxy.py +25 -0
- meta_reports/migrations/0032_alter_endpointsproxy_options.py +21 -0
- meta_reports/migrations/0033_auto_20240823_0012.py +54 -0
- meta_reports/migrations/0034_auto_20240823_1642.py +54 -0
- meta_reports/migrations/0035_historicalmissingogttnote_missingogttnote.py +457 -0
- meta_reports/migrations/0036_historicalmissingogttnote_fasting_and_more.py +86 -0
- meta_reports/migrations/0037_historicalmissingogttnote_result_status_and_more.py +51 -0
- meta_reports/migrations/0038_alter_historicalmissingogttnote_fasting_and_more.py +33 -0
- meta_reports/migrations/0039_onstudymissingvalues.py +44 -0
- meta_reports/migrations/0040_auto_20240824_0412.py +282 -0
- meta_reports/migrations/0041_auto_20240828_2229.py +14 -0
- meta_reports/migrations/0042_onstudymissinglabvalues.py +43 -0
- meta_reports/migrations/0043_auto_20240828_2309.py +88 -0
- meta_reports/migrations/0044_auto_20240828_2323.py +93 -0
- meta_reports/migrations/0045_auto_20240829_0248.py +54 -0
- meta_reports/migrations/0046_auto_20240829_0250.py +54 -0
- meta_reports/migrations/0047_impsubstitutions.py +56 -0
- meta_reports/migrations/0048_auto_20240909_2338.py +48 -0
- meta_reports/migrations/0049_auto_20240911_0327.py +54 -0
- meta_reports/migrations/0050_alter_endpoints_created.py +19 -0
- meta_reports/migrations/0051_remove_endpoints_baseline_datetime_and_more.py +40 -0
- meta_reports/migrations/0052_lastimpvisit.py +57 -0
- meta_reports/migrations/0053_rename_lastimpvisit_lastimprefill_and_more.py +31 -0
- meta_reports/models/__init__.py +16 -0
- meta_reports/models/dbviews/README +14 -0
- meta_reports/models/dbviews/__init__.py +9 -0
- meta_reports/models/dbviews/glucose_summary/__init__.py +2 -0
- meta_reports/models/dbviews/glucose_summary/unmanaged_model.py +35 -0
- meta_reports/models/dbviews/glucose_summary/view_definition.py +28 -0
- meta_reports/models/dbviews/imp_substitutions/__init__.py +1 -0
- meta_reports/models/dbviews/imp_substitutions/unmanaged_model.py +41 -0
- meta_reports/models/dbviews/imp_substitutions/view_definition.py +21 -0
- meta_reports/models/dbviews/missing_screening_ogtt/__init__.py +2 -0
- meta_reports/models/dbviews/missing_screening_ogtt/note_model.py +57 -0
- meta_reports/models/dbviews/missing_screening_ogtt/unmanaged_model.py +41 -0
- meta_reports/models/dbviews/missing_screening_ogtt/view_definition.py +20 -0
- meta_reports/models/dbviews/on_study_missing_lab_values/__init__.py +1 -0
- meta_reports/models/dbviews/on_study_missing_lab_values/qa_cases.py +53 -0
- meta_reports/models/dbviews/on_study_missing_lab_values/unmanged_model.py +20 -0
- meta_reports/models/dbviews/on_study_missing_lab_values/view_definition.py +17 -0
- meta_reports/models/dbviews/on_study_missing_values/__init__.py +1 -0
- meta_reports/models/dbviews/on_study_missing_values/qa_cases.py +54 -0
- meta_reports/models/dbviews/on_study_missing_values/unmanged_model.py +20 -0
- meta_reports/models/dbviews/on_study_missing_values/view_definition.py +17 -0
- meta_reports/models/dbviews/patient_history_missing_baseline_cd4/__init__.py +1 -0
- meta_reports/models/dbviews/patient_history_missing_baseline_cd4/unmanaged_model.py +31 -0
- meta_reports/models/dbviews/patient_history_missing_baseline_cd4/view_definition.py +21 -0
- meta_reports/models/dbviews/unattended_three_in_row/__init__.py +1 -0
- meta_reports/models/dbviews/unattended_three_in_row/unmanaged_model.py +29 -0
- meta_reports/models/dbviews/unattended_three_in_row/view_definition.py +31 -0
- meta_reports/models/dbviews/unattended_three_in_row2/__init__.py +1 -0
- meta_reports/models/dbviews/unattended_three_in_row2/unmanaged_model.py +29 -0
- meta_reports/models/dbviews/unattended_three_in_row2/view_definition.py +50 -0
- meta_reports/models/dbviews/unattended_two_in_row/__init__.py +1 -0
- meta_reports/models/dbviews/unattended_two_in_row/unmanaged_model.py +27 -0
- meta_reports/models/dbviews/unattended_two_in_row/view_definition.py +30 -0
- meta_reports/models/endpoints.py +31 -0
- meta_reports/models/endpoints_proxy.py +11 -0
- meta_reports/models/last_imp_refill.py +34 -0
- meta_reports/tasks.py +12 -0
- meta_reports/templates/meta_reports/columns/subject_identifier_column.html +1 -0
- meta_reports/templates/meta_reports/endpoints_all_change_list_note.html +12 -0
- meta_reports/templates/meta_reports/endpoints_change_list_note.html +12 -0
- meta_reports/tests/test_sql_gen.py +5 -0
- meta_reports/urls.py +8 -0
- meta_reports/utils.py +0 -0
- meta_screening/admin/subject_screening_admin.py +1 -0
- meta_screening/form_validators/screening_part_two.py +1 -1
- meta_screening/migrations/0062_remove_icpreferral_site_and_more.py +27 -0
- meta_screening/migrations/0063_alter_historicalscreeningpartone_fasting_duration_str_and_more.py +184 -0
- meta_screening/migrations/0064_remove_historicalscreeningpartone_fasting_duration_minutes_and_more.py +126 -0
- meta_screening/migrations/0065_auto_20240516_0352.py +31 -0
- meta_screening/migrations/0066_alter_historicalscreeningpartone_fasting_duration_delta_and_more.py +103 -0
- meta_screening/migrations/0067_alter_historicalscreeningpartone_report_datetime_and_more.py +84 -0
- meta_screening/models/__init__.py +1 -1
- meta_screening/tests/holidays.csv +1 -1
- meta_screening/tests/meta_test_case_mixin.py +17 -2
- meta_screening/tests/options.py +3 -3
- meta_sites/__init__.py +0 -1
- meta_sites/sites.py +8 -7
- meta_sites/tests/test_sites.py +1 -1
- meta_subject/action_items.py +25 -2
- meta_subject/admin/__init__.py +2 -1
- meta_subject/admin/birth_outcome_admin.py +4 -3
- meta_subject/admin/blood_results/__init__.py +1 -1
- meta_subject/admin/blood_results/{blood_results_lipid_admin.py → blood_results_lipids_admin.py} +7 -7
- meta_subject/admin/delivery_admin.py +0 -1
- meta_subject/admin/diabetes/__init__.py +2 -0
- meta_subject/admin/diabetes/dm_endpoint_admin.py +35 -0
- meta_subject/admin/{dm_referral_followup_admin.py → diabetes/dm_followup_admin.py} +15 -8
- meta_subject/admin/glucose_admin.py +1 -1
- meta_subject/admin/glucose_fbg_admin.py +38 -8
- meta_subject/admin/other_arv_regimens_admin.py +2 -0
- meta_subject/admin/study_medication_admin.py +10 -0
- meta_subject/admin/subject_visit_admin.py +4 -1
- meta_subject/baker_recipes.py +6 -0
- meta_subject/choices.py +8 -0
- meta_subject/constants.py +2 -1
- meta_subject/form_validators/__init__.py +2 -1
- meta_subject/form_validators/dm_endpoint_form_validator.py +35 -0
- meta_subject/form_validators/{dm_referral_followup_form_validator.py → dm_followup_form_validator.py} +41 -2
- meta_subject/forms/__init__.py +2 -1
- meta_subject/forms/blood_results/__init__.py +1 -1
- meta_subject/forms/blood_results/{blood_results_lipid_form.py → blood_results_lipids_form.py} +5 -5
- meta_subject/forms/diabetes/__init__.py +2 -0
- meta_subject/forms/diabetes/dm_endpoint_form.py +13 -0
- meta_subject/forms/diabetes/dm_followup_form.py +25 -0
- meta_subject/forms/glucose_fbg_form.py +38 -16
- meta_subject/forms/study_medication_form.py +35 -0
- meta_subject/forms/subject_visit_form.py +16 -0
- meta_subject/locale/lg/LC_MESSAGES/django.po +470 -0
- meta_subject/locale/sw/LC_MESSAGES/django.po +191 -89
- meta_subject/metadata_rules/metadata_rules.py +21 -0
- meta_subject/metadata_rules/predicates.py +67 -8
- meta_subject/migrations/0107_auto_20220415_0043.py +28 -22
- meta_subject/migrations/0126_auto_20220719_2142.py +4 -4
- meta_subject/migrations/0131_auto_20220722_0411.py +28 -23
- meta_subject/migrations/0132_auto_20220722_1825.py +10 -6
- meta_subject/migrations/0135_auto_20220722_2212.py +39 -35
- meta_subject/migrations/0150_auto_20220914_0039.py +15 -11
- meta_subject/migrations/0181_dmreferralfollowup_action_identifier_and_more.py +143 -0
- meta_subject/migrations/0182_rename_dmreferralfollowup_dmfollowup_and_more.py +54 -0
- meta_subject/migrations/0183_alter_dmfollowup_on_dm_medications_and_more.py +31 -0
- meta_subject/migrations/0184_alter_glucose_options_and_more.py +31 -0
- meta_subject/migrations/0185_alter_bloodresultsins_fasting_duration_str_and_more.py +82 -0
- meta_subject/migrations/0186_healtheconomicsupdate_singleton_field_and_more.py +55 -0
- meta_subject/migrations/0187_dmdiagnosis_historicaldmdiagnosis_dmdxresult_and_more.py +451 -0
- meta_subject/migrations/0188_historicaldmdxresult_dmdxresult.py +403 -0
- meta_subject/migrations/0189_alter_dmdxresult_options_and_more.py +116 -0
- meta_subject/migrations/0190_dmdiagnosis_dx_no_tmg_reason_and_more.py +65 -0
- meta_subject/migrations/0191_alter_dmdiagnosis_dx_no_tmg_reason_and_more.py +70 -0
- meta_subject/migrations/0192_rename_glucose_quantifier_glucosefbg_fbg_quantifier_and_more.py +44 -0
- meta_subject/migrations/0193_alter_glucosefbg_fbg_value_and_more.py +44 -0
- meta_subject/migrations/0194_remove_glucosefbg_assay_datetime_and_more.py +166 -0
- meta_subject/migrations/0195_alter_glucosefbg_fbg_datetime_and_more.py +27 -0
- meta_subject/migrations/0196_glucosefbg_fbg_not_performed_reason_and_more.py +49 -0
- meta_subject/migrations/0197_glucosefbg_fasting_duration_estimated_and_more.py +33 -0
- meta_subject/migrations/0198_alter_glucosefbg_fasting_duration_estimated_and_more.py +33 -0
- meta_subject/migrations/0199_auto_20240516_0247.py +18 -0
- meta_subject/migrations/0200_rename_fasting_duration_minutes_bloodresultsins_fasting_duration_delta_and_more.py +43 -0
- meta_subject/migrations/0201_alter_bloodresultsins_fasting_duration_delta_and_more.py +58 -0
- meta_subject/migrations/0202_auto_20240516_0315.py +32 -0
- meta_subject/migrations/0203_alter_bloodresultsins_fasting_duration_delta_and_more.py +67 -0
- meta_subject/migrations/0204_glucosefbg_repeat_fbg_date_and_more.py +27 -0
- meta_subject/migrations/0205_historicalsubjectrequisition_crf_status_and_more.py +80 -0
- meta_subject/migrations/0206_bloodresultsfbc_crf_status_and_more.py +62 -0
- meta_subject/migrations/0207_alter_historicalphysicalexam_waist_circumference_and_more.py +46 -0
- meta_subject/migrations/0208_birthoutcomes_crf_status_and_more.py +62 -0
- meta_subject/migrations/0209_remove_historicaldmdxresult_dm_diagnosis_and_more.py +37 -0
- meta_subject/migrations/0210_remove_dmdxresult_dm_diagnosis_and_more.py +123 -0
- meta_subject/migrations/0211_dmendpoint_endpoint_reached_and_more.py +45 -0
- meta_subject/migrations/0212_auto_20240827_2222.py +23 -0
- meta_subject/migrations/0213_rename_bloodresultslipid_bloodresultslipids_and_more.py +35 -0
- meta_subject/migrations/0214_historicalstudymedication_stock_codes_and_more.py +44 -0
- meta_subject/migrations/0215_alter_historicalstudymedication_stock_codes_and_more.py +46 -0
- meta_subject/model_mixins/arv_history_model_mixin.py +3 -3
- meta_subject/models/__init__.py +3 -2
- meta_subject/models/birth_outcomes.py +6 -1
- meta_subject/models/blood_results/__init__.py +1 -1
- meta_subject/models/blood_results/blood_results_fbc.py +3 -2
- meta_subject/models/blood_results/blood_results_hba1c.py +2 -0
- meta_subject/models/blood_results/blood_results_ins.py +2 -0
- meta_subject/models/blood_results/blood_results_lft.py +2 -0
- meta_subject/models/blood_results/{blood_results_lipid.py → blood_results_lipids.py} +5 -3
- meta_subject/models/blood_results/blood_results_rft.py +2 -0
- meta_subject/models/diabetes/__init__.py +2 -0
- meta_subject/models/diabetes/dm_endpoint.py +61 -0
- meta_subject/models/{dm_referral_followup.py → diabetes/dm_followup.py} +18 -6
- meta_subject/models/glucose.py +7 -14
- meta_subject/models/glucose_fbg.py +40 -51
- meta_subject/models/health_economics/health_economics_update.py +2 -0
- meta_subject/models/physical_exam.py +1 -0
- meta_subject/models/signals.py +19 -0
- meta_subject/models/subject_requisition.py +3 -4
- meta_subject/models/todo.txt +1 -1
- meta_subject/static/meta_subject/slider.css +1 -1
- meta_subject/templates/meta_subject/endpoint_review_instructions.html +1 -1
- meta_subject/templates/meta_subject/widgets/slider.html +0 -1
- meta_subject/tests/holidays.csv +1 -1
- meta_subject/tests/tests/test_egfr.py +6 -5
- meta_subject/tests/tests/test_medication_adherence.py +5 -1
- meta_subject/tests/tests/test_metadata_rules.py +34 -4
- meta_subject/tests/tests/test_mnsi.py +212 -121
- meta_subject/tests/tests/test_sf12.py +0 -12
- meta_visit_schedule/constants.py +7 -1
- meta_visit_schedule/tests/tests/test_schedule.py +4 -0
- meta_visit_schedule/visit_schedules/phase_three/crfs.py +87 -14
- meta_visit_schedule/visit_schedules/phase_three/requisitions.py +12 -0
- meta_visit_schedule/visit_schedules/phase_three/schedule.py +65 -2
- meta_visit_schedule/visit_schedules/phase_three/schedule_dm_referral.py +60 -0
- meta_visit_schedule/visit_schedules/phase_three/visit_schedule.py +2 -0
- tests/etc/randomization_list.csv +1 -1
- {meta_edc/tests → tests}/etc/randomization_list_phase_three.csv +4 -4
- tests/holidays.csv +1 -1
- tests/test_settings.py +186 -0
- meta_edc/tests/etc/user-aes-local.key +0 -1
- meta_edc/tests/etc/user-aes-restricted.key +0 -0
- meta_edc/tests/etc/user-rsa-local-private.pem +0 -27
- meta_edc/tests/etc/user-rsa-local-public.pem +0 -9
- meta_edc/tests/etc/user-rsa-restricted-private.pem +0 -27
- meta_edc/tests/etc/user-rsa-restricted-public.pem +0 -9
- meta_edc/tests/etc/user-salt-local.key +0 -0
- meta_edc/tests/etc/user-salt-restricted.key +0 -0
- meta_edc-0.3.7.dist-info/METADATA +0 -87
- meta_reports/tests/holidays.csv +0 -15
- meta_subject/forms/dm_referral_followup.py +0 -18
- /meta_edc-0.3.7.dist-info/AUTHORS → /meta_analytics/__init__.py +0 -0
- /meta_pharmacy/models.py → /meta_analytics/constants.py +0 -0
- /meta_reports/models.py → /meta_analytics/notebooks/cleaning/__init__.py +0 -0
- {meta_edc-0.3.7.dist-info → meta_edc-0.3.50.dist-info}/LICENSE +0 -0
@@ -0,0 +1,766 @@
|
|
1
|
+
Metadata-Version: 2.2
|
2
|
+
Name: meta-edc
|
3
|
+
Version: 0.3.50
|
4
|
+
Summary: META Trial EDC (http://www.isrctn.com/ISRCTN76157257)
|
5
|
+
Home-page: https://github.com/meta-trial/meta-edc
|
6
|
+
Author: Erik van Widenfelt
|
7
|
+
Author-email: Erik van Widenfelt <ew2789@gmail.com>, Jonathan Willitts <j.willitts@ucl.ac.uk>
|
8
|
+
License: GNU GENERAL PUBLIC LICENSE
|
9
|
+
Version 3, 29 June 2007
|
10
|
+
|
11
|
+
Copyright (C) 2007 Free Software Foundation, Inc. <https://fsf.org/>
|
12
|
+
Everyone is permitted to copy and distribute verbatim copies
|
13
|
+
of this license document, but changing it is not allowed.
|
14
|
+
|
15
|
+
Preamble
|
16
|
+
|
17
|
+
The GNU General Public License is a free, copyleft license for
|
18
|
+
software and other kinds of works.
|
19
|
+
|
20
|
+
The licenses for most software and other practical works are designed
|
21
|
+
to take away your freedom to share and change the works. By contrast,
|
22
|
+
the GNU General Public License is intended to guarantee your freedom to
|
23
|
+
share and change all versions of a program--to make sure it remains free
|
24
|
+
software for all its users. We, the Free Software Foundation, use the
|
25
|
+
GNU General Public License for most of our software; it applies also to
|
26
|
+
any other work released this way by its authors. You can apply it to
|
27
|
+
your programs, too.
|
28
|
+
|
29
|
+
When we speak of free software, we are referring to freedom, not
|
30
|
+
price. Our General Public Licenses are designed to make sure that you
|
31
|
+
have the freedom to distribute copies of free software (and charge for
|
32
|
+
them if you wish), that you receive source code or can get it if you
|
33
|
+
want it, that you can change the software or use pieces of it in new
|
34
|
+
free programs, and that you know you can do these things.
|
35
|
+
|
36
|
+
To protect your rights, we need to prevent others from denying you
|
37
|
+
these rights or asking you to surrender the rights. Therefore, you have
|
38
|
+
certain responsibilities if you distribute copies of the software, or if
|
39
|
+
you modify it: responsibilities to respect the freedom of others.
|
40
|
+
|
41
|
+
For example, if you distribute copies of such a program, whether
|
42
|
+
gratis or for a fee, you must pass on to the recipients the same
|
43
|
+
freedoms that you received. You must make sure that they, too, receive
|
44
|
+
or can get the source code. And you must show them these terms so they
|
45
|
+
know their rights.
|
46
|
+
|
47
|
+
Developers that use the GNU GPL protect your rights with two steps:
|
48
|
+
(1) assert copyright on the software, and (2) offer you this License
|
49
|
+
giving you legal permission to copy, distribute and/or modify it.
|
50
|
+
|
51
|
+
For the developers' and authors' protection, the GPL clearly explains
|
52
|
+
that there is no warranty for this free software. For both users' and
|
53
|
+
authors' sake, the GPL requires that modified versions be marked as
|
54
|
+
changed, so that their problems will not be attributed erroneously to
|
55
|
+
authors of previous versions.
|
56
|
+
|
57
|
+
Some devices are designed to deny users access to install or run
|
58
|
+
modified versions of the software inside them, although the manufacturer
|
59
|
+
can do so. This is fundamentally incompatible with the aim of
|
60
|
+
protecting users' freedom to change the software. The systematic
|
61
|
+
pattern of such abuse occurs in the area of products for individuals to
|
62
|
+
use, which is precisely where it is most unacceptable. Therefore, we
|
63
|
+
have designed this version of the GPL to prohibit the practice for those
|
64
|
+
products. If such problems arise substantially in other domains, we
|
65
|
+
stand ready to extend this provision to those domains in future versions
|
66
|
+
of the GPL, as needed to protect the freedom of users.
|
67
|
+
|
68
|
+
Finally, every program is threatened constantly by software patents.
|
69
|
+
States should not allow patents to restrict development and use of
|
70
|
+
software on general-purpose computers, but in those that do, we wish to
|
71
|
+
avoid the special danger that patents applied to a free program could
|
72
|
+
make it effectively proprietary. To prevent this, the GPL assures that
|
73
|
+
patents cannot be used to render the program non-free.
|
74
|
+
|
75
|
+
The precise terms and conditions for copying, distribution and
|
76
|
+
modification follow.
|
77
|
+
|
78
|
+
TERMS AND CONDITIONS
|
79
|
+
|
80
|
+
0. Definitions.
|
81
|
+
|
82
|
+
"This License" refers to version 3 of the GNU General Public License.
|
83
|
+
|
84
|
+
"Copyright" also means copyright-like laws that apply to other kinds of
|
85
|
+
works, such as semiconductor masks.
|
86
|
+
|
87
|
+
"The Program" refers to any copyrightable work licensed under this
|
88
|
+
License. Each licensee is addressed as "you". "Licensees" and
|
89
|
+
"recipients" may be individuals or organizations.
|
90
|
+
|
91
|
+
To "modify" a work means to copy from or adapt all or part of the work
|
92
|
+
in a fashion requiring copyright permission, other than the making of an
|
93
|
+
exact copy. The resulting work is called a "modified version" of the
|
94
|
+
earlier work or a work "based on" the earlier work.
|
95
|
+
|
96
|
+
A "covered work" means either the unmodified Program or a work based
|
97
|
+
on the Program.
|
98
|
+
|
99
|
+
To "propagate" a work means to do anything with it that, without
|
100
|
+
permission, would make you directly or secondarily liable for
|
101
|
+
infringement under applicable copyright law, except executing it on a
|
102
|
+
computer or modifying a private copy. Propagation includes copying,
|
103
|
+
distribution (with or without modification), making available to the
|
104
|
+
public, and in some countries other activities as well.
|
105
|
+
|
106
|
+
To "convey" a work means any kind of propagation that enables other
|
107
|
+
parties to make or receive copies. Mere interaction with a user through
|
108
|
+
a computer network, with no transfer of a copy, is not conveying.
|
109
|
+
|
110
|
+
An interactive user interface displays "Appropriate Legal Notices"
|
111
|
+
to the extent that it includes a convenient and prominently visible
|
112
|
+
feature that (1) displays an appropriate copyright notice, and (2)
|
113
|
+
tells the user that there is no warranty for the work (except to the
|
114
|
+
extent that warranties are provided), that licensees may convey the
|
115
|
+
work under this License, and how to view a copy of this License. If
|
116
|
+
the interface presents a list of user commands or options, such as a
|
117
|
+
menu, a prominent item in the list meets this criterion.
|
118
|
+
|
119
|
+
1. Source Code.
|
120
|
+
|
121
|
+
The "source code" for a work means the preferred form of the work
|
122
|
+
for making modifications to it. "Object code" means any non-source
|
123
|
+
form of a work.
|
124
|
+
|
125
|
+
A "Standard Interface" means an interface that either is an official
|
126
|
+
standard defined by a recognized standards body, or, in the case of
|
127
|
+
interfaces specified for a particular programming language, one that
|
128
|
+
is widely used among developers working in that language.
|
129
|
+
|
130
|
+
The "System Libraries" of an executable work include anything, other
|
131
|
+
than the work as a whole, that (a) is included in the normal form of
|
132
|
+
packaging a Major Component, but which is not part of that Major
|
133
|
+
Component, and (b) serves only to enable use of the work with that
|
134
|
+
Major Component, or to implement a Standard Interface for which an
|
135
|
+
implementation is available to the public in source code form. A
|
136
|
+
"Major Component", in this context, means a major essential component
|
137
|
+
(kernel, window system, and so on) of the specific operating system
|
138
|
+
(if any) on which the executable work runs, or a compiler used to
|
139
|
+
produce the work, or an object code interpreter used to run it.
|
140
|
+
|
141
|
+
The "Corresponding Source" for a work in object code form means all
|
142
|
+
the source code needed to generate, install, and (for an executable
|
143
|
+
work) run the object code and to modify the work, including scripts to
|
144
|
+
control those activities. However, it does not include the work's
|
145
|
+
System Libraries, or general-purpose tools or generally available free
|
146
|
+
programs which are used unmodified in performing those activities but
|
147
|
+
which are not part of the work. For example, Corresponding Source
|
148
|
+
includes interface definition files associated with source files for
|
149
|
+
the work, and the source code for shared libraries and dynamically
|
150
|
+
linked subprograms that the work is specifically designed to require,
|
151
|
+
such as by intimate data communication or control flow between those
|
152
|
+
subprograms and other parts of the work.
|
153
|
+
|
154
|
+
The Corresponding Source need not include anything that users
|
155
|
+
can regenerate automatically from other parts of the Corresponding
|
156
|
+
Source.
|
157
|
+
|
158
|
+
The Corresponding Source for a work in source code form is that
|
159
|
+
same work.
|
160
|
+
|
161
|
+
2. Basic Permissions.
|
162
|
+
|
163
|
+
All rights granted under this License are granted for the term of
|
164
|
+
copyright on the Program, and are irrevocable provided the stated
|
165
|
+
conditions are met. This License explicitly affirms your unlimited
|
166
|
+
permission to run the unmodified Program. The output from running a
|
167
|
+
covered work is covered by this License only if the output, given its
|
168
|
+
content, constitutes a covered work. This License acknowledges your
|
169
|
+
rights of fair use or other equivalent, as provided by copyright law.
|
170
|
+
|
171
|
+
You may make, run and propagate covered works that you do not
|
172
|
+
convey, without conditions so long as your license otherwise remains
|
173
|
+
in force. You may convey covered works to others for the sole purpose
|
174
|
+
of having them make modifications exclusively for you, or provide you
|
175
|
+
with facilities for running those works, provided that you comply with
|
176
|
+
the terms of this License in conveying all material for which you do
|
177
|
+
not control copyright. Those thus making or running the covered works
|
178
|
+
for you must do so exclusively on your behalf, under your direction
|
179
|
+
and control, on terms that prohibit them from making any copies of
|
180
|
+
your copyrighted material outside their relationship with you.
|
181
|
+
|
182
|
+
Conveying under any other circumstances is permitted solely under
|
183
|
+
the conditions stated below. Sublicensing is not allowed; section 10
|
184
|
+
makes it unnecessary.
|
185
|
+
|
186
|
+
3. Protecting Users' Legal Rights From Anti-Circumvention Law.
|
187
|
+
|
188
|
+
No covered work shall be deemed part of an effective technological
|
189
|
+
measure under any applicable law fulfilling obligations under article
|
190
|
+
11 of the WIPO copyright treaty adopted on 20 December 1996, or
|
191
|
+
similar laws prohibiting or restricting circumvention of such
|
192
|
+
measures.
|
193
|
+
|
194
|
+
When you convey a covered work, you waive any legal power to forbid
|
195
|
+
circumvention of technological measures to the extent such circumvention
|
196
|
+
is effected by exercising rights under this License with respect to
|
197
|
+
the covered work, and you disclaim any intention to limit operation or
|
198
|
+
modification of the work as a means of enforcing, against the work's
|
199
|
+
users, your or third parties' legal rights to forbid circumvention of
|
200
|
+
technological measures.
|
201
|
+
|
202
|
+
4. Conveying Verbatim Copies.
|
203
|
+
|
204
|
+
You may convey verbatim copies of the Program's source code as you
|
205
|
+
receive it, in any medium, provided that you conspicuously and
|
206
|
+
appropriately publish on each copy an appropriate copyright notice;
|
207
|
+
keep intact all notices stating that this License and any
|
208
|
+
non-permissive terms added in accord with section 7 apply to the code;
|
209
|
+
keep intact all notices of the absence of any warranty; and give all
|
210
|
+
recipients a copy of this License along with the Program.
|
211
|
+
|
212
|
+
You may charge any price or no price for each copy that you convey,
|
213
|
+
and you may offer support or warranty protection for a fee.
|
214
|
+
|
215
|
+
5. Conveying Modified Source Versions.
|
216
|
+
|
217
|
+
You may convey a work based on the Program, or the modifications to
|
218
|
+
produce it from the Program, in the form of source code under the
|
219
|
+
terms of section 4, provided that you also meet all of these conditions:
|
220
|
+
|
221
|
+
a) The work must carry prominent notices stating that you modified
|
222
|
+
it, and giving a relevant date.
|
223
|
+
|
224
|
+
b) The work must carry prominent notices stating that it is
|
225
|
+
released under this License and any conditions added under section
|
226
|
+
7. This requirement modifies the requirement in section 4 to
|
227
|
+
"keep intact all notices".
|
228
|
+
|
229
|
+
c) You must license the entire work, as a whole, under this
|
230
|
+
License to anyone who comes into possession of a copy. This
|
231
|
+
License will therefore apply, along with any applicable section 7
|
232
|
+
additional terms, to the whole of the work, and all its parts,
|
233
|
+
regardless of how they are packaged. This License gives no
|
234
|
+
permission to license the work in any other way, but it does not
|
235
|
+
invalidate such permission if you have separately received it.
|
236
|
+
|
237
|
+
d) If the work has interactive user interfaces, each must display
|
238
|
+
Appropriate Legal Notices; however, if the Program has interactive
|
239
|
+
interfaces that do not display Appropriate Legal Notices, your
|
240
|
+
work need not make them do so.
|
241
|
+
|
242
|
+
A compilation of a covered work with other separate and independent
|
243
|
+
works, which are not by their nature extensions of the covered work,
|
244
|
+
and which are not combined with it such as to form a larger program,
|
245
|
+
in or on a volume of a storage or distribution medium, is called an
|
246
|
+
"aggregate" if the compilation and its resulting copyright are not
|
247
|
+
used to limit the access or legal rights of the compilation's users
|
248
|
+
beyond what the individual works permit. Inclusion of a covered work
|
249
|
+
in an aggregate does not cause this License to apply to the other
|
250
|
+
parts of the aggregate.
|
251
|
+
|
252
|
+
6. Conveying Non-Source Forms.
|
253
|
+
|
254
|
+
You may convey a covered work in object code form under the terms
|
255
|
+
of sections 4 and 5, provided that you also convey the
|
256
|
+
machine-readable Corresponding Source under the terms of this License,
|
257
|
+
in one of these ways:
|
258
|
+
|
259
|
+
a) Convey the object code in, or embodied in, a physical product
|
260
|
+
(including a physical distribution medium), accompanied by the
|
261
|
+
Corresponding Source fixed on a durable physical medium
|
262
|
+
customarily used for software interchange.
|
263
|
+
|
264
|
+
b) Convey the object code in, or embodied in, a physical product
|
265
|
+
(including a physical distribution medium), accompanied by a
|
266
|
+
written offer, valid for at least three years and valid for as
|
267
|
+
long as you offer spare parts or customer support for that product
|
268
|
+
model, to give anyone who possesses the object code either (1) a
|
269
|
+
copy of the Corresponding Source for all the software in the
|
270
|
+
product that is covered by this License, on a durable physical
|
271
|
+
medium customarily used for software interchange, for a price no
|
272
|
+
more than your reasonable cost of physically performing this
|
273
|
+
conveying of source, or (2) access to copy the
|
274
|
+
Corresponding Source from a network server at no charge.
|
275
|
+
|
276
|
+
c) Convey individual copies of the object code with a copy of the
|
277
|
+
written offer to provide the Corresponding Source. This
|
278
|
+
alternative is allowed only occasionally and noncommercially, and
|
279
|
+
only if you received the object code with such an offer, in accord
|
280
|
+
with subsection 6b.
|
281
|
+
|
282
|
+
d) Convey the object code by offering access from a designated
|
283
|
+
place (gratis or for a charge), and offer equivalent access to the
|
284
|
+
Corresponding Source in the same way through the same place at no
|
285
|
+
further charge. You need not require recipients to copy the
|
286
|
+
Corresponding Source along with the object code. If the place to
|
287
|
+
copy the object code is a network server, the Corresponding Source
|
288
|
+
may be on a different server (operated by you or a third party)
|
289
|
+
that supports equivalent copying facilities, provided you maintain
|
290
|
+
clear directions next to the object code saying where to find the
|
291
|
+
Corresponding Source. Regardless of what server hosts the
|
292
|
+
Corresponding Source, you remain obligated to ensure that it is
|
293
|
+
available for as long as needed to satisfy these requirements.
|
294
|
+
|
295
|
+
e) Convey the object code using peer-to-peer transmission, provided
|
296
|
+
you inform other peers where the object code and Corresponding
|
297
|
+
Source of the work are being offered to the general public at no
|
298
|
+
charge under subsection 6d.
|
299
|
+
|
300
|
+
A separable portion of the object code, whose source code is excluded
|
301
|
+
from the Corresponding Source as a System Library, need not be
|
302
|
+
included in conveying the object code work.
|
303
|
+
|
304
|
+
A "User Product" is either (1) a "consumer product", which means any
|
305
|
+
tangible personal property which is normally used for personal, family,
|
306
|
+
or household purposes, or (2) anything designed or sold for incorporation
|
307
|
+
into a dwelling. In determining whether a product is a consumer product,
|
308
|
+
doubtful cases shall be resolved in favor of coverage. For a particular
|
309
|
+
product received by a particular user, "normally used" refers to a
|
310
|
+
typical or common use of that class of product, regardless of the status
|
311
|
+
of the particular user or of the way in which the particular user
|
312
|
+
actually uses, or expects or is expected to use, the product. A product
|
313
|
+
is a consumer product regardless of whether the product has substantial
|
314
|
+
commercial, industrial or non-consumer uses, unless such uses represent
|
315
|
+
the only significant mode of use of the product.
|
316
|
+
|
317
|
+
"Installation Information" for a User Product means any methods,
|
318
|
+
procedures, authorization keys, or other information required to install
|
319
|
+
and execute modified versions of a covered work in that User Product from
|
320
|
+
a modified version of its Corresponding Source. The information must
|
321
|
+
suffice to ensure that the continued functioning of the modified object
|
322
|
+
code is in no case prevented or interfered with solely because
|
323
|
+
modification has been made.
|
324
|
+
|
325
|
+
If you convey an object code work under this section in, or with, or
|
326
|
+
specifically for use in, a User Product, and the conveying occurs as
|
327
|
+
part of a transaction in which the right of possession and use of the
|
328
|
+
User Product is transferred to the recipient in perpetuity or for a
|
329
|
+
fixed term (regardless of how the transaction is characterized), the
|
330
|
+
Corresponding Source conveyed under this section must be accompanied
|
331
|
+
by the Installation Information. But this requirement does not apply
|
332
|
+
if neither you nor any third party retains the ability to install
|
333
|
+
modified object code on the User Product (for example, the work has
|
334
|
+
been installed in ROM).
|
335
|
+
|
336
|
+
The requirement to provide Installation Information does not include a
|
337
|
+
requirement to continue to provide support service, warranty, or updates
|
338
|
+
for a work that has been modified or installed by the recipient, or for
|
339
|
+
the User Product in which it has been modified or installed. Access to a
|
340
|
+
network may be denied when the modification itself materially and
|
341
|
+
adversely affects the operation of the network or violates the rules and
|
342
|
+
protocols for communication across the network.
|
343
|
+
|
344
|
+
Corresponding Source conveyed, and Installation Information provided,
|
345
|
+
in accord with this section must be in a format that is publicly
|
346
|
+
documented (and with an implementation available to the public in
|
347
|
+
source code form), and must require no special password or key for
|
348
|
+
unpacking, reading or copying.
|
349
|
+
|
350
|
+
7. Additional Terms.
|
351
|
+
|
352
|
+
"Additional permissions" are terms that supplement the terms of this
|
353
|
+
License by making exceptions from one or more of its conditions.
|
354
|
+
Additional permissions that are applicable to the entire Program shall
|
355
|
+
be treated as though they were included in this License, to the extent
|
356
|
+
that they are valid under applicable law. If additional permissions
|
357
|
+
apply only to part of the Program, that part may be used separately
|
358
|
+
under those permissions, but the entire Program remains governed by
|
359
|
+
this License without regard to the additional permissions.
|
360
|
+
|
361
|
+
When you convey a copy of a covered work, you may at your option
|
362
|
+
remove any additional permissions from that copy, or from any part of
|
363
|
+
it. (Additional permissions may be written to require their own
|
364
|
+
removal in certain cases when you modify the work.) You may place
|
365
|
+
additional permissions on material, added by you to a covered work,
|
366
|
+
for which you have or can give appropriate copyright permission.
|
367
|
+
|
368
|
+
Notwithstanding any other provision of this License, for material you
|
369
|
+
add to a covered work, you may (if authorized by the copyright holders of
|
370
|
+
that material) supplement the terms of this License with terms:
|
371
|
+
|
372
|
+
a) Disclaiming warranty or limiting liability differently from the
|
373
|
+
terms of sections 15 and 16 of this License; or
|
374
|
+
|
375
|
+
b) Requiring preservation of specified reasonable legal notices or
|
376
|
+
author attributions in that material or in the Appropriate Legal
|
377
|
+
Notices displayed by works containing it; or
|
378
|
+
|
379
|
+
c) Prohibiting misrepresentation of the origin of that material, or
|
380
|
+
requiring that modified versions of such material be marked in
|
381
|
+
reasonable ways as different from the original version; or
|
382
|
+
|
383
|
+
d) Limiting the use for publicity purposes of names of licensors or
|
384
|
+
authors of the material; or
|
385
|
+
|
386
|
+
e) Declining to grant rights under trademark law for use of some
|
387
|
+
trade names, trademarks, or service marks; or
|
388
|
+
|
389
|
+
f) Requiring indemnification of licensors and authors of that
|
390
|
+
material by anyone who conveys the material (or modified versions of
|
391
|
+
it) with contractual assumptions of liability to the recipient, for
|
392
|
+
any liability that these contractual assumptions directly impose on
|
393
|
+
those licensors and authors.
|
394
|
+
|
395
|
+
All other non-permissive additional terms are considered "further
|
396
|
+
restrictions" within the meaning of section 10. If the Program as you
|
397
|
+
received it, or any part of it, contains a notice stating that it is
|
398
|
+
governed by this License along with a term that is a further
|
399
|
+
restriction, you may remove that term. If a license document contains
|
400
|
+
a further restriction but permits relicensing or conveying under this
|
401
|
+
License, you may add to a covered work material governed by the terms
|
402
|
+
of that license document, provided that the further restriction does
|
403
|
+
not survive such relicensing or conveying.
|
404
|
+
|
405
|
+
If you add terms to a covered work in accord with this section, you
|
406
|
+
must place, in the relevant source files, a statement of the
|
407
|
+
additional terms that apply to those files, or a notice indicating
|
408
|
+
where to find the applicable terms.
|
409
|
+
|
410
|
+
Additional terms, permissive or non-permissive, may be stated in the
|
411
|
+
form of a separately written license, or stated as exceptions;
|
412
|
+
the above requirements apply either way.
|
413
|
+
|
414
|
+
8. Termination.
|
415
|
+
|
416
|
+
You may not propagate or modify a covered work except as expressly
|
417
|
+
provided under this License. Any attempt otherwise to propagate or
|
418
|
+
modify it is void, and will automatically terminate your rights under
|
419
|
+
this License (including any patent licenses granted under the third
|
420
|
+
paragraph of section 11).
|
421
|
+
|
422
|
+
However, if you cease all violation of this License, then your
|
423
|
+
license from a particular copyright holder is reinstated (a)
|
424
|
+
provisionally, unless and until the copyright holder explicitly and
|
425
|
+
finally terminates your license, and (b) permanently, if the copyright
|
426
|
+
holder fails to notify you of the violation by some reasonable means
|
427
|
+
prior to 60 days after the cessation.
|
428
|
+
|
429
|
+
Moreover, your license from a particular copyright holder is
|
430
|
+
reinstated permanently if the copyright holder notifies you of the
|
431
|
+
violation by some reasonable means, this is the first time you have
|
432
|
+
received notice of violation of this License (for any work) from that
|
433
|
+
copyright holder, and you cure the violation prior to 30 days after
|
434
|
+
your receipt of the notice.
|
435
|
+
|
436
|
+
Termination of your rights under this section does not terminate the
|
437
|
+
licenses of parties who have received copies or rights from you under
|
438
|
+
this License. If your rights have been terminated and not permanently
|
439
|
+
reinstated, you do not qualify to receive new licenses for the same
|
440
|
+
material under section 10.
|
441
|
+
|
442
|
+
9. Acceptance Not Required for Having Copies.
|
443
|
+
|
444
|
+
You are not required to accept this License in order to receive or
|
445
|
+
run a copy of the Program. Ancillary propagation of a covered work
|
446
|
+
occurring solely as a consequence of using peer-to-peer transmission
|
447
|
+
to receive a copy likewise does not require acceptance. However,
|
448
|
+
nothing other than this License grants you permission to propagate or
|
449
|
+
modify any covered work. These actions infringe copyright if you do
|
450
|
+
not accept this License. Therefore, by modifying or propagating a
|
451
|
+
covered work, you indicate your acceptance of this License to do so.
|
452
|
+
|
453
|
+
10. Automatic Licensing of Downstream Recipients.
|
454
|
+
|
455
|
+
Each time you convey a covered work, the recipient automatically
|
456
|
+
receives a license from the original licensors, to run, modify and
|
457
|
+
propagate that work, subject to this License. You are not responsible
|
458
|
+
for enforcing compliance by third parties with this License.
|
459
|
+
|
460
|
+
An "entity transaction" is a transaction transferring control of an
|
461
|
+
organization, or substantially all assets of one, or subdividing an
|
462
|
+
organization, or merging organizations. If propagation of a covered
|
463
|
+
work results from an entity transaction, each party to that
|
464
|
+
transaction who receives a copy of the work also receives whatever
|
465
|
+
licenses to the work the party's predecessor in interest had or could
|
466
|
+
give under the previous paragraph, plus a right to possession of the
|
467
|
+
Corresponding Source of the work from the predecessor in interest, if
|
468
|
+
the predecessor has it or can get it with reasonable efforts.
|
469
|
+
|
470
|
+
You may not impose any further restrictions on the exercise of the
|
471
|
+
rights granted or affirmed under this License. For example, you may
|
472
|
+
not impose a license fee, royalty, or other charge for exercise of
|
473
|
+
rights granted under this License, and you may not initiate litigation
|
474
|
+
(including a cross-claim or counterclaim in a lawsuit) alleging that
|
475
|
+
any patent claim is infringed by making, using, selling, offering for
|
476
|
+
sale, or importing the Program or any portion of it.
|
477
|
+
|
478
|
+
11. Patents.
|
479
|
+
|
480
|
+
A "contributor" is a copyright holder who authorizes use under this
|
481
|
+
License of the Program or a work on which the Program is based. The
|
482
|
+
work thus licensed is called the contributor's "contributor version".
|
483
|
+
|
484
|
+
A contributor's "essential patent claims" are all patent claims
|
485
|
+
owned or controlled by the contributor, whether already acquired or
|
486
|
+
hereafter acquired, that would be infringed by some manner, permitted
|
487
|
+
by this License, of making, using, or selling its contributor version,
|
488
|
+
but do not include claims that would be infringed only as a
|
489
|
+
consequence of further modification of the contributor version. For
|
490
|
+
purposes of this definition, "control" includes the right to grant
|
491
|
+
patent sublicenses in a manner consistent with the requirements of
|
492
|
+
this License.
|
493
|
+
|
494
|
+
Each contributor grants you a non-exclusive, worldwide, royalty-free
|
495
|
+
patent license under the contributor's essential patent claims, to
|
496
|
+
make, use, sell, offer for sale, import and otherwise run, modify and
|
497
|
+
propagate the contents of its contributor version.
|
498
|
+
|
499
|
+
In the following three paragraphs, a "patent license" is any express
|
500
|
+
agreement or commitment, however denominated, not to enforce a patent
|
501
|
+
(such as an express permission to practice a patent or covenant not to
|
502
|
+
sue for patent infringement). To "grant" such a patent license to a
|
503
|
+
party means to make such an agreement or commitment not to enforce a
|
504
|
+
patent against the party.
|
505
|
+
|
506
|
+
If you convey a covered work, knowingly relying on a patent license,
|
507
|
+
and the Corresponding Source of the work is not available for anyone
|
508
|
+
to copy, free of charge and under the terms of this License, through a
|
509
|
+
publicly available network server or other readily accessible means,
|
510
|
+
then you must either (1) cause the Corresponding Source to be so
|
511
|
+
available, or (2) arrange to deprive yourself of the benefit of the
|
512
|
+
patent license for this particular work, or (3) arrange, in a manner
|
513
|
+
consistent with the requirements of this License, to extend the patent
|
514
|
+
license to downstream recipients. "Knowingly relying" means you have
|
515
|
+
actual knowledge that, but for the patent license, your conveying the
|
516
|
+
covered work in a country, or your recipient's use of the covered work
|
517
|
+
in a country, would infringe one or more identifiable patents in that
|
518
|
+
country that you have reason to believe are valid.
|
519
|
+
|
520
|
+
If, pursuant to or in connection with a single transaction or
|
521
|
+
arrangement, you convey, or propagate by procuring conveyance of, a
|
522
|
+
covered work, and grant a patent license to some of the parties
|
523
|
+
receiving the covered work authorizing them to use, propagate, modify
|
524
|
+
or convey a specific copy of the covered work, then the patent license
|
525
|
+
you grant is automatically extended to all recipients of the covered
|
526
|
+
work and works based on it.
|
527
|
+
|
528
|
+
A patent license is "discriminatory" if it does not include within
|
529
|
+
the scope of its coverage, prohibits the exercise of, or is
|
530
|
+
conditioned on the non-exercise of one or more of the rights that are
|
531
|
+
specifically granted under this License. You may not convey a covered
|
532
|
+
work if you are a party to an arrangement with a third party that is
|
533
|
+
in the business of distributing software, under which you make payment
|
534
|
+
to the third party based on the extent of your activity of conveying
|
535
|
+
the work, and under which the third party grants, to any of the
|
536
|
+
parties who would receive the covered work from you, a discriminatory
|
537
|
+
patent license (a) in connection with copies of the covered work
|
538
|
+
conveyed by you (or copies made from those copies), or (b) primarily
|
539
|
+
for and in connection with specific products or compilations that
|
540
|
+
contain the covered work, unless you entered into that arrangement,
|
541
|
+
or that patent license was granted, prior to 28 March 2007.
|
542
|
+
|
543
|
+
Nothing in this License shall be construed as excluding or limiting
|
544
|
+
any implied license or other defenses to infringement that may
|
545
|
+
otherwise be available to you under applicable patent law.
|
546
|
+
|
547
|
+
12. No Surrender of Others' Freedom.
|
548
|
+
|
549
|
+
If conditions are imposed on you (whether by court order, agreement or
|
550
|
+
otherwise) that contradict the conditions of this License, they do not
|
551
|
+
excuse you from the conditions of this License. If you cannot convey a
|
552
|
+
covered work so as to satisfy simultaneously your obligations under this
|
553
|
+
License and any other pertinent obligations, then as a consequence you may
|
554
|
+
not convey it at all. For example, if you agree to terms that obligate you
|
555
|
+
to collect a royalty for further conveying from those to whom you convey
|
556
|
+
the Program, the only way you could satisfy both those terms and this
|
557
|
+
License would be to refrain entirely from conveying the Program.
|
558
|
+
|
559
|
+
13. Use with the GNU Affero General Public License.
|
560
|
+
|
561
|
+
Notwithstanding any other provision of this License, you have
|
562
|
+
permission to link or combine any covered work with a work licensed
|
563
|
+
under version 3 of the GNU Affero General Public License into a single
|
564
|
+
combined work, and to convey the resulting work. The terms of this
|
565
|
+
License will continue to apply to the part which is the covered work,
|
566
|
+
but the special requirements of the GNU Affero General Public License,
|
567
|
+
section 13, concerning interaction through a network will apply to the
|
568
|
+
combination as such.
|
569
|
+
|
570
|
+
14. Revised Versions of this License.
|
571
|
+
|
572
|
+
The Free Software Foundation may publish revised and/or new versions of
|
573
|
+
the GNU General Public License from time to time. Such new versions will
|
574
|
+
be similar in spirit to the present version, but may differ in detail to
|
575
|
+
address new problems or concerns.
|
576
|
+
|
577
|
+
Each version is given a distinguishing version number. If the
|
578
|
+
Program specifies that a certain numbered version of the GNU General
|
579
|
+
Public License "or any later version" applies to it, you have the
|
580
|
+
option of following the terms and conditions either of that numbered
|
581
|
+
version or of any later version published by the Free Software
|
582
|
+
Foundation. If the Program does not specify a version number of the
|
583
|
+
GNU General Public License, you may choose any version ever published
|
584
|
+
by the Free Software Foundation.
|
585
|
+
|
586
|
+
If the Program specifies that a proxy can decide which future
|
587
|
+
versions of the GNU General Public License can be used, that proxy's
|
588
|
+
public statement of acceptance of a version permanently authorizes you
|
589
|
+
to choose that version for the Program.
|
590
|
+
|
591
|
+
Later license versions may give you additional or different
|
592
|
+
permissions. However, no additional obligations are imposed on any
|
593
|
+
author or copyright holder as a result of your choosing to follow a
|
594
|
+
later version.
|
595
|
+
|
596
|
+
15. Disclaimer of Warranty.
|
597
|
+
|
598
|
+
THERE IS NO WARRANTY FOR THE PROGRAM, TO THE EXTENT PERMITTED BY
|
599
|
+
APPLICABLE LAW. EXCEPT WHEN OTHERWISE STATED IN WRITING THE COPYRIGHT
|
600
|
+
HOLDERS AND/OR OTHER PARTIES PROVIDE THE PROGRAM "AS IS" WITHOUT WARRANTY
|
601
|
+
OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO,
|
602
|
+
THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR
|
603
|
+
PURPOSE. THE ENTIRE RISK AS TO THE QUALITY AND PERFORMANCE OF THE PROGRAM
|
604
|
+
IS WITH YOU. SHOULD THE PROGRAM PROVE DEFECTIVE, YOU ASSUME THE COST OF
|
605
|
+
ALL NECESSARY SERVICING, REPAIR OR CORRECTION.
|
606
|
+
|
607
|
+
16. Limitation of Liability.
|
608
|
+
|
609
|
+
IN NO EVENT UNLESS REQUIRED BY APPLICABLE LAW OR AGREED TO IN WRITING
|
610
|
+
WILL ANY COPYRIGHT HOLDER, OR ANY OTHER PARTY WHO MODIFIES AND/OR CONVEYS
|
611
|
+
THE PROGRAM AS PERMITTED ABOVE, BE LIABLE TO YOU FOR DAMAGES, INCLUDING ANY
|
612
|
+
GENERAL, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES ARISING OUT OF THE
|
613
|
+
USE OR INABILITY TO USE THE PROGRAM (INCLUDING BUT NOT LIMITED TO LOSS OF
|
614
|
+
DATA OR DATA BEING RENDERED INACCURATE OR LOSSES SUSTAINED BY YOU OR THIRD
|
615
|
+
PARTIES OR A FAILURE OF THE PROGRAM TO OPERATE WITH ANY OTHER PROGRAMS),
|
616
|
+
EVEN IF SUCH HOLDER OR OTHER PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF
|
617
|
+
SUCH DAMAGES.
|
618
|
+
|
619
|
+
17. Interpretation of Sections 15 and 16.
|
620
|
+
|
621
|
+
If the disclaimer of warranty and limitation of liability provided
|
622
|
+
above cannot be given local legal effect according to their terms,
|
623
|
+
reviewing courts shall apply local law that most closely approximates
|
624
|
+
an absolute waiver of all civil liability in connection with the
|
625
|
+
Program, unless a warranty or assumption of liability accompanies a
|
626
|
+
copy of the Program in return for a fee.
|
627
|
+
|
628
|
+
END OF TERMS AND CONDITIONS
|
629
|
+
|
630
|
+
How to Apply These Terms to Your New Programs
|
631
|
+
|
632
|
+
If you develop a new program, and you want it to be of the greatest
|
633
|
+
possible use to the public, the best way to achieve this is to make it
|
634
|
+
free software which everyone can redistribute and change under these terms.
|
635
|
+
|
636
|
+
To do so, attach the following notices to the program. It is safest
|
637
|
+
to attach them to the start of each source file to most effectively
|
638
|
+
state the exclusion of warranty; and each file should have at least
|
639
|
+
the "copyright" line and a pointer to where the full notice is found.
|
640
|
+
|
641
|
+
<one line to give the program's name and a brief idea of what it does.>
|
642
|
+
Copyright (C) <year> <name of author>
|
643
|
+
|
644
|
+
This program is free software: you can redistribute it and/or modify
|
645
|
+
it under the terms of the GNU General Public License as published by
|
646
|
+
the Free Software Foundation, either version 3 of the License, or
|
647
|
+
(at your option) any later version.
|
648
|
+
|
649
|
+
This program is distributed in the hope that it will be useful,
|
650
|
+
but WITHOUT ANY WARRANTY; without even the implied warranty of
|
651
|
+
MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. See the
|
652
|
+
GNU General Public License for more details.
|
653
|
+
|
654
|
+
You should have received a copy of the GNU General Public License
|
655
|
+
along with this program. If not, see <https://www.gnu.org/licenses/>.
|
656
|
+
|
657
|
+
Also add information on how to contact you by electronic and paper mail.
|
658
|
+
|
659
|
+
If the program does terminal interaction, make it output a short
|
660
|
+
notice like this when it starts in an interactive mode:
|
661
|
+
|
662
|
+
<program> Copyright (C) <year> <name of author>
|
663
|
+
This program comes with ABSOLUTELY NO WARRANTY; for details type `show w'.
|
664
|
+
This is free software, and you are welcome to redistribute it
|
665
|
+
under certain conditions; type `show c' for details.
|
666
|
+
|
667
|
+
The hypothetical commands `show w' and `show c' should show the appropriate
|
668
|
+
parts of the General Public License. Of course, your program's commands
|
669
|
+
might be different; for a GUI interface, you would use an "about box".
|
670
|
+
|
671
|
+
You should also get your employer (if you work as a programmer) or school,
|
672
|
+
if any, to sign a "copyright disclaimer" for the program, if necessary.
|
673
|
+
For more information on this, and how to apply and follow the GNU GPL, see
|
674
|
+
<https://www.gnu.org/licenses/>.
|
675
|
+
|
676
|
+
The GNU General Public License does not permit incorporating your program
|
677
|
+
into proprietary programs. If your program is a subroutine library, you
|
678
|
+
may consider it more useful to permit linking proprietary applications with
|
679
|
+
the library. If this is what you want to do, use the GNU Lesser General
|
680
|
+
Public License instead of this License. But first, please read
|
681
|
+
<https://www.gnu.org/licenses/why-not-lgpl.html>.
|
682
|
+
|
683
|
+
Keywords: django,clinicedc,META EDC,EDC,clinical trials
|
684
|
+
Classifier: Environment :: Web Environment
|
685
|
+
Classifier: Framework :: Django
|
686
|
+
Classifier: Framework :: Django :: 5.1
|
687
|
+
Classifier: Intended Audience :: Developers
|
688
|
+
Classifier: Intended Audience :: Science/Research
|
689
|
+
Classifier: Operating System :: OS Independent
|
690
|
+
Classifier: Programming Language :: Python :: 3.12
|
691
|
+
Classifier: License :: OSI Approved :: GNU General Public License v3 (GPLv3)
|
692
|
+
Requires-Python: >=3.12
|
693
|
+
Description-Content-Type: text/x-rst
|
694
|
+
License-File: LICENSE
|
695
|
+
License-File: AUTHORS
|
696
|
+
Requires-Dist: edc==0.6.24
|
697
|
+
Requires-Dist: edc-microscopy
|
698
|
+
Requires-Dist: beautifulsoup4
|
699
|
+
Requires-Dist: celery[redis]
|
700
|
+
Requires-Dist: django-pylabels
|
701
|
+
|
702
|
+
|pypi| |actions| |codecov| |downloads|
|
703
|
+
|
704
|
+
|
705
|
+
META Edc
|
706
|
+
--------
|
707
|
+
|
708
|
+
Metformin treatment in Africa- META
|
709
|
+
|
710
|
+
* https://www.ucl.ac.uk/global-health/research/z-research/respond-africa/metformin-treatment-africa-meta
|
711
|
+
* https://www.inteafrica.org/related-projects/meta-trial/
|
712
|
+
* https://www.lstmed.ac.uk/research/departments/international-public-health/respond-africa/meta
|
713
|
+
* http://www.isrctn.com/ISRCTN76157257
|
714
|
+
|
715
|
+
py 3.12 / DJ 5.1 / edc 0.6.0 (META3)
|
716
|
+
|
717
|
+
This codebase is used for two randomized clinical trials:
|
718
|
+
|
719
|
+
____
|
720
|
+
|
721
|
+
META PHASE II:
|
722
|
+
|
723
|
+
(final version `0.1.77 <https://github.com/meta-trial/meta-edc/tree/0.1.77>`_)
|
724
|
+
|
725
|
+
Metformin Treatment for Diabetes Prevention in Africa: META Trial
|
726
|
+
TASO, MRC/UVRI/LSHTM, NIMR – TZ and Liverpool School of Tropical Medicine (ISRCTN76157257)
|
727
|
+
http://www.isrctn.com/ISRCTN76157257
|
728
|
+
|
729
|
+
____
|
730
|
+
|
731
|
+
META PHASE III:
|
732
|
+
|
733
|
+
A randomised placebo-controlled double-blind phase III trial to determine the effects of metformin versus placebo on the incidence of diabetes in HIV-infected persons with pre-diabetes in Tanzania.
|
734
|
+
|
735
|
+
Liverpool School of Tropical Medicine
|
736
|
+
|
737
|
+
EDCTP grant number: RIA2018CO-2513
|
738
|
+
|
739
|
+
Trial registration: ISCRTN 77382043
|
740
|
+
|
741
|
+
https://ico.org.uk/ESDWebPages/Entry/Z4763134
|
742
|
+
|
743
|
+
____
|
744
|
+
|
745
|
+
See also https://github.com/clinicedc/edc
|
746
|
+
|
747
|
+
|django|
|
748
|
+
|
749
|
+
To setup a demo system, see https://github.com/meta-trial/meta3-sample
|
750
|
+
|
751
|
+
|
752
|
+
.. |pypi| image:: https://img.shields.io/pypi/v/meta-edc.svg
|
753
|
+
:target: https://pypi.python.org/pypi/meta-edc
|
754
|
+
|
755
|
+
.. |actions| image:: https://github.com/meta-trial/meta-edc/actions/workflows/build.yml/badge.svg
|
756
|
+
:target: https://github.com/meta-trial/meta-edc/actions/workflows/build.yml
|
757
|
+
|
758
|
+
.. |codecov| image:: https://codecov.io/gh/meta-trial/meta-edc/branch/develop/graph/badge.svg
|
759
|
+
:target: https://codecov.io/gh/meta-trial/meta-edc
|
760
|
+
|
761
|
+
.. |downloads| image:: https://pepy.tech/badge/meta-edc
|
762
|
+
:target: https://pepy.tech/project/meta-edc
|
763
|
+
|
764
|
+
.. |django| image:: https://www.djangoproject.com/m/img/badges/djangomade124x25.gif
|
765
|
+
:target: http://www.djangoproject.com/
|
766
|
+
:alt: Made with Django
|